Hormonal activity of the hypophysial-gonadal axis versus the mineral bone density and specific markers of bone turnover in haemodialysis population;Aktywność hormonalna osi przysadkowo-gonadalnej a gȩstość mineralna kości i wskaźniki metabolizmu kostnego u chorych przewlekle hemodializowanych

Polski Merkuriusz Lekarski

Volumn 20, Issue 118, 2006, Pages 408-412

  Kurnatowska, Ilona ^a   Zygmunt, Arkadiusz ^a   Fijałkowska Morawska, Jolanta ^a   Białkowska, Jolanta ^a   Jabłkowski, Maciej ^a   Nowicki, Michał ^a   Lewiński, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Bone mineral density; Gonadal status; Markers of bone turnover; Renal osteodystrophy

Indexed keywords

ALKALINE PHOSPHATASE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; OSTEOCALCIN; TESTOSTERONE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HEMODIALYSIS; HORMONE ACTION; HUMAN; HYPOPHYSIS GONAD SYSTEM; MALE; OSTEOPOROSIS; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; BONE DENSITY; COMORBIDITY; FEMALE; HUMANS; HYPOGONADISM; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSTEOPOROSIS; RENAL DIALYSIS; RISK FACTORS; SEX DISTRIBUTION;

EID: 33646549933     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Avbersek-Luznik I., Balon B.P., Rus I. i wsp.: Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Nephrol. Dial. Transplant., 2005, 20(3), 566-570.
2. Bilezikian J.P.: Estrogens and postmenopausal osteoporosis: was Albright right after all? J. Bone. Miner. Res., 1998, 13(5), 774-776.
3. Christgau S., Rosenquist C., Alexandersen P. i wsp.: Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. Clin. Chem., 1998, 44(11), 2290-2300.
4. Cunningham J., Sprague S.M., Cannata-Andia J. i wsp.: Osteoporosis in chronic kidney disease. Am. J. Kidney Dis., 2004, 43(3), 566-571.
5. Czekalski S.: Osteoporoza w chorobach nerek. Terapia, 2005, 2(2), 18-21.
6. Fontaine M., Albert A., Dubois R. i wsp.: Fracture and bone mineral density in haemodialysis patients. Clin. Nephrol., 2000, 54(3), 218-226.
7. Holley J.L.: The hypothalamic-pituitary axis in men and women with chronic kidney disease. Adv. Chronic Kidney Dis., 2004, 11(4), 337-341.
8. Jȩdrzejczak P., Serdyńska M.: Harmony płciowe a osteoporoza u mȩżczyzn. Terapia, 2005, 2(2), 24-26.
9. Karczmarewicz E.: Wartość diagnostyczna markerów obrotu kostnego - uzgodnienia 2000. W: Diagnostyka osteoporozy 2000. Lorenc R.S. (red.). Osteoforum, Warszawa 2000, 233-249.
10. Magnusson P., Sharp C.A., Magnusson M. i wsp.: Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int., 2001, 60(1), 257-265.
11. Matuszkiewicz-Rowinska J., Skorzewska K., Radowicki S. i wsp.: Menstrual disturbances and alternations in hypophyseal gonadal axis in end-stage premenopausal women undergoing hemodialysis: a multi-center study. Pol. Arch. Med. Wewn., 2003, 109(6), 609-615.
12. Reichel H., Roth H.J., Schmidt-Gayk H.: Evaluation of serum beta-carboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients. Nephron. Clin. Pract., 2004, 98(4), 112-118.
13. Stehman-Breen C., Sherrard D., Alem A. i wsp.: Rise factors for hip fracture among patients with end-stange renal disease. Kidney Int., 2000, 58(5), 2200-2205.
14. Stein M.S., Packham D.K., Ebeling P.R. i wsp.: Prevalence and risk factors for osteopenia in dialysis patients. Am. J. Kidney Dis., 1996, 28(4), 515-522.
15. Taal M.W., Cassidy M.J., Pearson D. i wsp.: Usefulness of quantitative heel ultrasound compared with dual-energy X-ray absorptiometry in determining bone mineral density in chronic haemodialysis patients. Nephrol. Dial. Transplant., 1999, 14(8), 1917-1921.
16. Urena P., Bernard-Poenaru O., Ostertag A. i wsp.: Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol. Dial. Transplant., 2003, 18(11), 2325-2331.
17. Urena P., de Vernejoul M.C.: Circulating markers of bone remodelling in uremic patients. Kidney Int., 1999, 55(6), 2141-2156.
18. Weisinger J.R., Gonzalez L., Alvarez H. i wsp.: Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women. Kidney Int., 2000, 58(1), 331-335.
19. Zamd M., Farh M., Hbid O. i wsp.: Sexual dysfunction among 78 Moroccan male hemodialysis patients: clinical and endocrine study. Ann. Endocrinol. (Paris), 2004, 65(3), 94-200.